REFRACTORY LUNG SMALL CELL CARCINOMA

Clinical trials for REFRACTORY LUNG SMALL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LUNG SMALL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Early trial tests new drug combo for Tough-to-Treat cancers

Disease control Ongoing

This early-stage study aims to find the safest and most effective dose of a new drug, M6620, when given with the chemotherapy drug irinotecan. It is for adults with advanced solid tumors, like certain colorectal, pancreatic, or lung cancers, that have spread or cannot be removed …

Matched conditions: REFRACTORY LUNG SMALL CELL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

REFRACTORY LUNG SMALL CELL CARCINOMA

Get alerted when new REFRACTORY LUNG SMALL CELL CARCINOMA trials appear

Early trial tests new drug combo for Tough-to-Treat cancers